Journal of orthopaedic trauma
-
To compare orthopaedic trauma volume and mechanism of injury before and during statewide social distancing and stay-at-home directives. ⋯ Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
-
Observational Study
Thirty-Day Mortality Rate of Patients With Hip Fractures During the COVID-19 Pandemic: A Single Centre Prospective Study in the United Kingdom.
During the COVID-19 pandemic, the care of hip fracture patients remains a clinical priority. Our study aims to investigate the 30-day mortality rate of hip fracture patients during the first 30 days of the pandemic in the United Kingdom. ⋯ Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.
-
To evaluate the effect of the COVID-19 pandemic and the "shelter-in-place" order on orthopaedic trauma presenting to a community level II trauma center. It is hypothesized that the overall number of orthopaedic trauma encounters (OTEs), the number of OTEs related to both high and low severity injuries, and the proportion of OTEs related to high severity versus low severity injuries decreased compared with previous years. ⋯ Therapeutic Level III. See Instructions for Authors for a complete description of Levels of Evidence.
-
To compare reoperation risk after total elbow arthroplasty (TEA) and open reduction internal fixation (ORIF) for intra-articular distal humerus fractures in elderly patients. ⋯ Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
-
(1) To demonstrate how a risk assessment tool modified to account for the COVID-19 virus during the current global pandemic is able to provide risk assessment for low-energy geriatric hip fracture patients. (2) To provide a treatment algorithm for care of COVID-19 positive/suspected hip fractures patients that accounts for their increased risk of morbidity and mortality. ⋯ Prognostic Level III. See Instructions for Authors for a complete description of Levels of Evidence.